We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+9%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
AUM
$344M
AUM Growth
+$52.5M
Cap. Flow
+$42.4M
Cap. Flow %
12.33%
Top 10 Hldgs %
52.51%
Holding
54
New
17
Increased
13
Reduced
2
Closed
18

Top Buys

Rank Stock Value
1
BAK icon
Braskem
BAK
+$16.6M
2
CNDT icon
Conduent
CNDT
+$15.2M
3
HRTX icon
Heron Therapeutics
HRTX
+$14.5M
4
ADEA icon
Adeia
ADEA
+$14.2M
5
GPK icon
Graphic Packaging
GPK
+$13.5M

Top Sells

Rank Stock Value
1
OLN icon
Olin
OLN
+$17.3M
2
SIG icon
Signet Jewelers
SIG
+$13.4M
3
VYX icon
NCR Voyix
VYX
+$10.7M
4
DK icon
Delek US
DK
+$6.94M
5
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$6.94M

Sector Composition

Rank Sector Weight
1 Technology 25.3%
2 Healthcare 13.22%
3 Industrials 9.77%
4 Materials 9.3%
5 Energy 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGN
51
DELISTED
Allergan plc
AGN
-12,400
Closed -$2.6M
SHLD
52
PUT
DELISTED
Sears Holding Corporation
SHLD
-200,000
Closed -$1.86M
REGI
53
DELISTED
Renewable Energy Group, Inc.
REGI
-500,000
Closed -$4.85M

Similar funds

Rubric Capital Management (New York)'s Q1 2017 Portfolio in Review

As of Q1 2017, Rubric Capital Management (New York) held 54 positions worth $344M, up 18% from $291M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Rubric Capital Management (New York) deployed $42.4M of net new capital in Q1 2017, opening 17 new positions and adding to 13 existing holdings. Its largest new stake was Conduent: 1,000,000 shares worth $16.8M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Ironwood Pharmaceuticals, an estimated $6.94M trimmed.

  • Rubric Capital Management (New York)'s largest Q1 2017 buy was Conduent: 1,000,000 shares worth $16.8M.
  • Rubric Capital Management (New York) added most to Braskem in Q1 2017, an estimated $16.6M increase.
  • Rubric Capital Management (New York)'s biggest Q1 2017 reduction was Ironwood Pharmaceuticals, cutting an estimated $6.94M.
  • Rubric Capital Management (New York) fully exited Olin in Q1 2017, selling an estimated $17.3M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 53% of its $344M portfolio in Q1 2017.
  • Rubric Capital Management (New York) opened 17 new positions and closed 18 in Q1 2017.
  • Rubric Capital Management (New York)'s portfolio value rose 18% quarter-over-quarter to $344M.

Based on Rubric Capital Management (New York)'s 13F filing for Q1 2017, filed 28 Apr 2017.